Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Omalizumab (Atc Code: R03Dx05).

AOK Niedersachsen. Die Gesundheitskasse. Germany has Released a tender for Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Omalizumab (Atc Code: R03Dx05). in Healthcare and Medicine. The tender was released on Oct 08, 2024.

Country - Germany

Summary - Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Omalizumab (Atc Code: R03Dx05).

Deadline - Sep 27, 2026

MT reference number - 95075157

Product classification - Medical equipments, pharmaceuticals and personal care products

Organization Details:

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 95075157

  Document Type - Tender Notices

Notice Details and Documents:

Description - Description: Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Omalizumab (Atc Code: R03Dx05).notice_title: Conclusion Of A Non-Exclusive Discount Agre ement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Omalizumab (Atc Code: R03Dx05).local description: : Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Omalizumab (ATC-Code: R03DX05).local title:: Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Omalizumab (ATC-Code: R03DX

Mt Ref Id - 95075157

Deadline - Sep 27, 2026

Share

Similar Tenders :